World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
43738
World Ranking
11988
National Ranking
6147

Overview

Kirkwood F. Adams is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in the subfield of Cardiology and Cardiovascular Medicine.

Their published work addresses multiple topics including:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Diabetes Treatment and Management
  • Cardiac Structural Anomalies and Repair
  • Health Systems, Economic Evaluations, Quality of Life
  • Pregnancy-related medical research

Key representative papers by Kirkwood F. Adams include:

  • Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure, 2020, published in the New England Journal of Medicine
  • Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure, 2023, published in JAMA
  • Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial, 2020, published in JAMA Cardiology
  • Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure, 2024, published in the Journal of the American College of Cardiology
  • Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial, 2020, published via UNC Libraries

Frequent co-authors collaborating with Kirkwood F. Adams include:

  • G. Michael Felker
  • David J. Whellan
  • Mona Fiuzat
  • Christopher M. O'Connor
  • Ileana L. Piña

Their scholarly output is most often published in venues such as:

  • UNC Libraries
  • European Journal of Heart Failure
  • Journal of Cardiac Failure
  • Journal of the American College of Cardiology
  • Circulation Heart Failure

Best Publications

  • Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)

    Kirkwood F. Adams;Gregg C. Fonarow;Charles L. Emerman;Thierry H. LeJemtel

  • Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

    Anne L Taylor;Susan Ziesche;Clyde Yancy;Peter Carson

  • Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness

    James A. Hill;Daniel F. Pauly;Debra R. Olitsky;Stuart Russell

  • Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure

    Michael R. Bristow;Edward M. Gilbert;William T. Abraham;Kirkwood F. Adams

  • Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure: Classification and Regression Tree Analysis

    Gregg C. Fonarow;Kirkwood F. Adams;William T. Abraham;Clyde W. Yancy

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

    Michael S. Cuffe;Robert M. Califf;Kirkwood F. Adams;Raymond Benza

  • State of the art: using natriuretic peptide levels in clinical practice.

    Alan Maisel;Alan Maisel;Christian Mueller;Kirkwood Adams;Stefan D. Anker

  • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

    John R Teerlink;Gad Cotter;Beth A Davison;G Michael Felker

  • Executive summary: HFSA 2006 comprehensive heart failure practice guideline

    Kirkwood F. Adams;Jo Ann Lindenfeld;J. Malcolm O. Arnold;David W. Baker

  • Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.

    Milton Packer;Milton Packer;Mihai Gheorghiade;James B. Young;Peter J. Costantini

  • In-Hospital Mortality in Patients With Acute Decompensated Heart Failure Requiring Intravenous Vasoactive Medications: An Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE)

    William T. Abraham;Kirkwood F. Adams;Gregg C. Fonarow;Maria Rosa Costanzo

  • Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized with Worsening Heart Failure: A Randomized Controlled Trial

    Mihai Gheorghiade;Wendy A. Gattis;Christopher M. O'Connor;Kirkwood F. Adams

  • A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

    Robert M. Califf;Kirkwood F. Adams;William J. McKenna;Mihai Gheorghiade

  • Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure The Ancillary Digitalis Investigation Group Trial

    Ali Ahmed;Michael W. Rich;Jerome L. Fleg;Michael R. Zile

  • Consensus recommendations for the management of chronic heart failure: Introduction

    Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci

  • Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.

    Liviu Klein;Christopher M. O'Connor;Jeffrey D. Leimberger;Wendy Gattis-Stough

  • Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).

    Christopher M. O'Connor;Wendy A. Gattis;Barry F. Uretsky;Kirkwood F. Adams

  • HFSA 2006 comprehensive heart failure practice guideline

    Kirkwood F. Adams;Jo Ann Lindenfeld;J. Malcolm O. Arnold;David W. Baker

  • Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

    A.L. Taylor;S. Ziesche;C. Yancy

Frequent Co-Authors

Mihai Gheorghiade
Mihai Gheorghiade Northwestern University
G. Michael Felker
G. Michael Felker Duke University
David J. Whellan
David J. Whellan Thomas Jefferson University
Faiez Zannad
Faiez Zannad University of Lorraine
Gregg C. Fonarow
Gregg C. Fonarow University of California, Los Angeles
John R. Teerlink
John R. Teerlink University of California, San Francisco
Javed Butler
Javed Butler University of Mississippi
William E. Kraus
William E. Kraus Duke University
Gary G. Koch
Gary G. Koch University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to various online degrees and specialized career paths beyond the traditional MD. Students who wish to rapidly advance in the healthcare industry often pursue an affordable mha online, which focuses on leadership, administration, and operational aspects of healthcare facilities.

For those pursuing advanced nursing roles, enrolling in one of the best dnp programs online can be an ideal step. A Doctor of Nursing Practice degree can pave the way to specialized clinical and executive positions in healthcare.

Pharmacy is another rewarding discipline. Professionals looking for a streamlined, flexible pathway can benefit from a 3 year online pharmd program, allowing them to complete a doctorate in pharmacy efficiently while maintaining current employment or responsibilities.

Lastly, technology-driven students may consider an online mhi degree. This prepares graduates for careers in health data management, health informatics, and technology integration within healthcare systems.

Best Scientists Citing Kirkwood F. Adams

Trending Scientists